PubMed:17006606 / 1527-1683
Annnotations
LitCoin-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T9 | 0-156 | Sentence | denotes | In particular, subjects with stage IV had a two times higher probability of having either IL1B-31TT (or IL1B-511CC) genotype compared with stage I subjects. |
LitCoin-entities
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| 3438 | 90-94 | GeneOrGeneProduct | denotes | IL1B | NCBIGene:3553 |
| 3439 | 94-99 | SequenceVariant | denotes | -31TT | DBSNP:rs1143627 |
| 3440 | 104-108 | GeneOrGeneProduct | denotes | IL1B | NCBIGene:3553 |
| 3441 | 108-114 | SequenceVariant | denotes | -511CC | DBSNP:rs1143634 |
LitCoin-SeqVar
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T5 | 94-99 | SequenceVariant | denotes | -31TT |
| T6 | 108-114 | SequenceVariant | denotes | -511CC |
LitCoin-GeneOrGeneProduct-v0
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T33 | 38-43 | GeneOrGeneProduct | denotes | had a |
| T34 | 48-53 | GeneOrGeneProduct | denotes | times |
| T35 | 61-72 | GeneOrGeneProduct | denotes | probability |
| T36 | 90-94 | GeneOrGeneProduct | denotes | IL1B |
| T37 | 104-108 | GeneOrGeneProduct | denotes | IL1B |
LitCoin-GeneOrGeneProduct-v2
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T21 | 90-94 | GeneOrGeneProduct | denotes | IL1B |
| T22 | 104-108 | GeneOrGeneProduct | denotes | IL1B |
LitCoin-GeneOrGeneProduct-v3
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T15 | 90-94 | GeneOrGeneProduct | denotes | IL1B |
| T16 | 104-108 | GeneOrGeneProduct | denotes | IL1B |
LitCoin-training-merged
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T16 | 104-108 | GeneOrGeneProduct | denotes | IL1B |
| T15 | 90-94 | GeneOrGeneProduct | denotes | IL1B |
| T66692 | 108-114 | SequenceVariant | denotes | -511CC |
| T10474 | 94-99 | SequenceVariant | denotes | -31TT |